| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A longitudinal analysis of chronic arm morbidity following breast cancer surgery
|
Boquiren, Virginia M.
|
|
2016
|
157 |
3 |
p. 413-425
|
article
|
| 2 |
A single-center, randomized, parallel controlled study comparing the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer
|
Zhou, Yijun
|
|
2016
|
157 |
3 |
p. 527-534
|
article
|
| 3 |
Associations between metabolic syndrome, breast cancer recurrence, and the 21-gene recurrence score assay
|
Muniz, Jeanette
|
|
2016
|
157 |
3 |
p. 597-603
|
article
|
| 4 |
Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry
|
Wirtz, Ralph M.
|
|
2016
|
157 |
3 |
p. 437-446
|
article
|
| 5 |
Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer
|
Chen, Lu
|
|
2016
|
157 |
3 |
p. 545-554
|
article
|
| 6 |
Great tumour burden in the axilla may influence lymphatic drainage in breast cancer patients
|
Zhou, Wenbin
|
|
2016
|
157 |
3 |
p. 503-510
|
article
|
| 7 |
Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation
|
Szalayova, Gabriela
|
|
2016
|
157 |
3 |
p. 461-474
|
article
|
| 8 |
Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based study
|
Gong, Inna Y.
|
|
2016
|
157 |
3 |
p. 535-544
|
article
|
| 9 |
Long-term consequences of ovarian ablation for premenopausal breast cancer
|
Kwon, Janice S.
|
|
2016
|
157 |
3 |
p. 565-573
|
article
|
| 10 |
Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy
|
Liu, Ying L.
|
|
2016
|
157 |
3 |
p. 555-564
|
article
|
| 11 |
Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations
|
Lewin, R.
|
|
2016
|
157 |
3 |
p. 511-516
|
article
|
| 12 |
Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources
|
Akinyemiju, Tomi
|
|
2016
|
157 |
3 |
p. 575-586
|
article
|
| 13 |
Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer
|
Robles, Andrew J.
|
|
2016
|
157 |
3 |
p. 475-488
|
article
|
| 14 |
Survival and disease-free benefits with mastectomy versus breast conservation therapy for early breast cancer: a meta-analysis
|
Chen, Yan
|
|
2016
|
157 |
3 |
p. 517-525
|
article
|
| 15 |
Therapeutic inhibition of breast cancer bone metastasis progression and lung colonization: breaking the vicious cycle by targeting α5β1 integrin
|
Yao, Hongren
|
|
2016
|
157 |
3 |
p. 489-501
|
article
|
| 16 |
Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis
|
Di Meglio, Antonio
|
|
2016
|
157 |
3 |
p. 587-596
|
article
|
| 17 |
Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancers
|
Singh, Kamaljeet
|
|
2016
|
157 |
3 |
p. 405-411
|
article
|
| 18 |
Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis
|
Orucevic, Amila
|
|
2016
|
157 |
3 |
p. 427-435
|
article
|
| 19 |
Validation of an oligo-gene signature for the prognostic stratification of ductal carcinoma in situ (DCIS)
|
Geradts, Joseph
|
|
2016
|
157 |
3 |
p. 447-459
|
article
|
Journal description